Antibody Production in planta

Comprehensive Biotechnology, Second Edition

Volumn 4, Issue , 2011, Pages 287-300

  Meyers, A J ^a   Grohs, B M ^a   Hall, J C ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Agrobacterium; Antibody; Biopharming; Magnifection; Plant transformation; Purification; Therapeutic

Indexed keywords

EID: 85012854259     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00271-3     Document Type: Chapter

References (50)

1. Hiatt A., Cafferkey R., Bowdish K. Production of antibodies in transgenic plants. Nature 1989, 342:76-78.
2. Fischer R., Schillberg S., Twyman R.M. Molecular farming of antibodies in plants. Recent Advances in Plant Biotechnology 2009, 35-63. Springer US, New York. A. Kirakosyan, P. Kaufman (Eds.).
3. Gomord V., Fitchette A., Menu-Bouaouiche L., et al. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnology Journal 2010, 8:564-587.
4. Gelvin S.B. Agrobacterium-mediated plant transformation: The biology behind the 'gene-jockeying' tool. Microbiology and Molecular Biology Review 2003, 67:16-37.
5. McLean M.D., Almquist K.C., Niu Y., et al. A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro. Antimicrobial Agents and Chemotherapy 2007, 51:3322-3328.
6. De Muynck B., Navarre C., Boutry M. Production of antibodies in plants: Status after twenty years. Plant Biotechnology Journal 2010, 8:529-563.
7. Olea-Popelka F., McLean M.D., Horsman J., et al. Increasing expression of an anti-picloram single-chain variable fragment (scFv) antibody and resistance to picloram in transgenic tobacco (Nicotiana tabacum). Journal of Agricultural and Food Chemistry 2005, 53:6683-6690.
8. Nikolov Z.L., Regan J.T., Dickey L.F., Woodard S.L. Purification of antibodies from transgenic plants. Process Scale Purification of Antibodies 2009, 387-406. John Wiley & Sons, Inc., Hoboken. U. Gottschalk (Ed.).
9. Barcelo P., Lazzeri P. Direct gene transfer: Chemical, electrical and physical methods. Transgenic Plant Research 1998, 35-55. Harwood Academic Publishers, Amsterdam. K. Lindsay (Ed.).
10. Hefferon K. Biopharmaceuticals in Plants: Towards the Next Century of Medicine 2010, CRC Press Taylor & Francis Group, Boca Raton, FL.
11. Gleba Y., Klimyuk V., Marillonnet S. Viral vectors for the expression of proteins in plants. Current Opinion in Biotechnology 2007, 18:134-141.
12. Marillonnet S., Giritch A., Gils M., et al. In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:6852-6857.
13. Marillonnet S., Thoeringer C., Kandzia R., et al. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nature Biotechnology 2005, 23:718-723.
14. Bendandi M., Marillonnet S., Kandzia R., et al. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Annals of Oncology 2010, 21:2420-2427.
15. Stöger E., Vaquero C., Torres E., et al. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Molecular Biology 2000, 42:583-590.
16. Torres E., Vaquero C., Nicholson L., et al. Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies. Transgenic Research 1999, 8:441-449.
17. Schillberg S., Fischer R., Emans N. Molecular farming of recombinant antibodies in plants. Cellular and Molecular Life Sciences 2003, 60:433-445.
18. Gomord V., Sourrouille C., Fitchette A., et al. Production and glycosylation of plant-made pharmaceuticals: The antibodies as a challenge. Plant Biotechnology Journal 2004, 2:83-100.
19. Stöger E., Sack M., Nicholson L., et al. Recent progress in plantibody technology. Current Pharmaceutical Design 2005, 11:2439-2457.
20. Villani M.E., Morgun B., Brunetti P., et al. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. Plant Biotechnology Journal 2009, 7:59-72.
21. Cox K.M., Sterling J.D., Regan J.T., et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nature Biotechnology 2006, 24:1591-1597.
22. Strasser R., Stadlmann J., Schähs M., et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnology Journal 2008, 6:392-402.
23. Hassan S., van Dolleweerd C.J., Ioakeimidis F., et al. Considerations for extraction of monoclonal antibodies targeted to different subcellular compartments in transgenic tobacco plants. Plant Biotechnology Journal 2008, 6:733-748.
24. Platis D., Drossard J., Fischer R., et al. New downstream processing strategy for the purification of monoclonal antibodies from transgenic tobacco plants. Journal of Chromatography A 2008, 1211:80-89.
25. Roque A., Lowe C., Taipa M. Antibodies and genetically engineered related molecules: Production and purification. Biotechnology Progress 2004, 20:639-654.
26. Menkhaus T.J., Bai Y., Zhang C., et al. Considerations for the recovery of recombinant proteins from plants. Biotechnology Progress 2004, 20:1001-1014.
27. Platis D., Labrou N.E. Development of an aqueous two-phase partitioning system for fractionating therapeutic proteins from tobacco extract. Journal of Chromatography A 2006, 1128:114-124.
28. Seon J., Szarka S., Moloney M. A unique strategy for recovering recombinant proteins from molecular farming: Affinity capture on engineered oilbodies. Journal of Plant Biotechnology 2002, 4:95-101.
29. Saxena A., Tripathi B.P., Kumar M., Shahi V.K. Membrane-based techniques for the separation and purification of proteins: An overview. Advances in Colloid and Interface Science 2009, 145:1-22.
30. Zeman L., Zydney A. Module Design and Membrane Configurations 1996, Marcel Dekker Inc., New York.
31. Stöger E., Schillberg S., Twyman R.M., et al. Antibody production in transgenic plants. Antibody Engineering - Methods and Protocols 2004, 301-318. Humana Press Inc., Totowa. B.K. Lo (Ed.).
32. Hussack G., Grohs B.M., Almquist K.C., et al. Purification of plant-derived antibodies through direct immobilization of affinity ligands on cellulose. Journal of Agricultural and Food Chemistry 2010, 58:3451-3459.
33. Schillberg S., Zimmermann S., Zhang M.Y., Fischer R. Antibody-based resistance to plant pathogens. Transgenic Research 2001, 10:1-12.
34. Ko K., Brodzik R., Steplewski Z. Production of antibodies in plants: Approaches and perspectives. Plant-Produced Microbial Vaccines 2009, 55-78. Springer-Verlag, Berlin: Heidelberg. A. Karasev (Ed.).
35. Le Gall F., Bov J., Garnier M. Engineering of a single-chain variable-fragment (scFv) antibody specific for the stolbur phytoplasma (Mollicute) and its expression in Escherichia coli and tobacco plants. Applied and Environmental Microbiology 1998, 64:4566-4572.
36. Zimmermann S., Schillberg S., Liao Y., Fischer R. Intracellular expression of TMV-specific single-chain Fv fragments leads to improved virus resistance in shape Nicotiana tabacum. Molecular Breeding 1998, 4:369-379.
37. Jobling S.A., Jarman C., Teh M., et al. Immunomodulation of enzyme function in plants by single-domain antibody fragments. Nature Biotechnology 2003, 21:77-80.
38. Miroshnichenko S., Tripp J., Nieden U., et al. Immunomodulation of function of small heat shock proteins prevents their assembly into heat stress granules and results in cell death at sublethal temperatures. The Plant Journal: For Cell and Molecular Biology 2005, 41:269-281.
39. Almquist K.C., Niu Y., McLean M.D., et al. Immunomodulation confers herbicide resistance in plants. Plant Biotechnology Journal 2004, 2:189-197.
40. Barbi T., Drake P.M.W., Drever M., et al. Generation of transgenic plants expressing plasma membrane-bound antibodies to the environmental pollutant microcystin-LR. Transgenic Research 2010, 10.1007/s11248-010-9431-4.
41. Drake P.M.W., Barbi T., Drever M.R., et al. Generation of transgenic plants expressing antibodies to the environmental pollutant microcystin-LR. FASEB Journal 2010, 24:882-890.
42. Khoudi H., Laberge S., Ferullo J.M., et al. Production of a diagnostic monoclonal antibody in perennial alfalfa plants. Biotechnology and Bioengineering 1999, 64:135-143.
43. Grohs B.M., Niu Y., Veldhuis L.J., et al. Plant-produced trastuzumab inhibits the growth of HER2 positive cancer cells. Journal of Agricultural and Food Chemistry 2010, 51:10056-10063.
44. Ma J.K., Lehner T., Stabila P., et al. Assembly of monoclonal antibodies with IgG1 and IgA heavy-chain domains in transgenic tobacco plants. European Journal of Immunology 1994, 24:131-138.
45. Ma J.K., Hikmat B.Y., Wycoff K., et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nature Medicine 1998, 4:601-606.
46. Xie X., McLean M.D., Hall J.C. Antibody-dependent cell-mediated cytotoxicity- and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad. Journal of Immunology 2010, 184:3725-3733.
47. Zeitlin L., Olmsted S.S., Moench T.R., et al. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nature Biotechnology 1998, 16:1361-1364.
48. Pogue G.P., Vojdani F., Palmer K.E., et al. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnology Journal 2010, 8:638-654.
49. Rademacher T., Sack M., Arcalis E., et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnology Journal 2008, 6:189-201.
50. Floss D.M., Sack M., Stadlmann J., et al. Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnology Journal 2008, 6:379-391.